MedPath

A research study of behavioural activation treatment for depression for adolescents with mild to moderate intellectual disability

Not Applicable
Conditions
Treatment of depression in adolescents with mild to moderate learning disability
Mental and Behavioural Disorders
Registration Number
ISRCTN15930742
Lead Sponsor
niversity of Warwick
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
20
Inclusion Criteria

1. Adolescents with a mild to moderate intellectual disability, defined by a score of 70 or below on standardised assessments and deficits in adaptive functioning, and/or administratively defined as having an intellectual disability, for example, enrolled in a special school for children/adolescents with mild intellectual disability
2. Adolescents with the capacity to assent/consent to take part in the research (and therefore would have sufficient communication and understanding to take part in the treatment)
3. Aged 12-17 years
4. Clinically significant unipolar depression as determined using information gathered through clinical interview (Anxiety Disorder Interview Schedule for Children)
5. Has support from a family member or paid carer who can support them throughout the treatment
6. If on medication for depressive symptoms, have been on a stable dose for 4 weeks prior to commencement of intervention

Exclusion Criteria

1. A suicide attempt in the past 6 months
2. Intensive inpatient treatment for mental illness in the past 6 months
3. Factors that prevent the young person from interacting with the supporter and therapist or retaining information from the therapy (for example, severe psychosis, degenerative condition)
4. Currently receiving any psychological therapy for a mental health problem
5. Insufficient English language skills to complete the measures or participate in the treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in depressive symptoms measured using the self-reported Glasgow Depression Scale for People with Intellectual Disability (GDS) at baseline and 4 months post-randomisation
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath